Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH
Journal: Frontiers in immunology
Treatment Used: Pegcetacoplan
Number of Patients: 1
Published: December 19, 2022

The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Terapevticheskii arkhiv
Treatment Used: Eculizumab Biosimilar
Number of Patients: 28
Published: October 26, 2022

Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life.

Condition: Pregnancy in Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Terapevticheskii arkhiv
Treatment Used: Eculizumab
Number of Patients: 49
Published: October 26, 2022

MDS-136 Rapid Time to a Clinically Meaningful Response in FACIT-Fatigue Scores With Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria: A Kaplan-Meier Analysis from the PEGASUS Trial.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pegcetacoplan
Number of Patients: 80
Published: September 27, 2022

MDS-254 A Matching-Adjusted Indirect Comparison of the Efficacy of Pegcetacoplan using PRINCE Trial Data versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pegcetacoplan
Number of Patients: 280
Published: September 27, 2022

MDS-113 Pegcetacoplan Rapidly Stabilizes Complement-Inhibitor Naïve Patients With Paroxysmal Nocturnal Hemoglobinuria Experiencing Hemolysis With Acute Hemoglobin Decreases: A Post Hoc Analysis from the Phase 3 PRINCE Trial.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pegcetacoplan
Number of Patients: 53
Published: September 27, 2022

MDS-111 Hemoglobin, Lactate Dehydrogenase, and FACIT-Fatigue Normalization in Pegcetacoplan-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria from Two Phase 3 Clinical Trials.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Pegcetacoplan
Number of Patients: 53
Published: September 27, 2022

Subacute stent thrombosis with spontaneously resolved secondary thrombi in paroxysmal nocturnal hemoglobinuria: a case report.

Condition: Stent Thrombosis (ST) in Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: BMC cardiovascular disorders
Treatment Used: Antithrombotic Therapy
Number of Patients: 1
Published: September 12, 2022

The role of the alternative pathway in paroxysmal nocturnal hemoglobinuria and emerging treatments.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Expert review of clinical pharmacology
Treatment Used: C5 Inhibitors and Biosimilars
Number of Patients: 0
Published: August 18, 2022

Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Seminars in immunology
Treatment Used: C3 Targeting Therapies
Number of Patients: 0
Published: June 28, 2022

Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience.

Condition: Pregnant Polish Women with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Treatment Used: Eculizumab
Number of Patients: 3
Published: June 14, 2022

Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.

Condition: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Journal: European journal of haematology
Treatment Used: Ravulizumab
Number of Patients: 41
Published: May 03, 2022
Showing 1-12 of 45

Last Updated: 01/20/2023